Navigation Links
Technology reveals 'lock and key' proteins behind diseases

A new technology developed at the University of Toronto is revealing biochemical processes responsible for diseases such as cystic fibrosis and could one day pave the way for pharmaceutical applications.

A study appearing in the April 13 issue of Molecular Cell describes how U of T and Johns Hopkins University researchers designed a device to test for proteins that play an important role in human health and disease. The technology, iMYTH (or integrated membrane yeast-two hybrid system), scans cells to detect proteins that interact with key proteins called ATP-binding cassette (ABC) transporters ?proteins that, when impaired, can cause disease. One of the best known ABC transporters is the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), which, when disabled by mutation, causes cystic fibrosis, a hereditary disease that results in progressive disability and early death. Another important ABC protein is the Multidrug Resistance Protein (MRP), which normally removes drug metabolites and toxins from cells in our bodies but when overzealous can contribute to the drug resistance of tumours, thereby thwarting chemotherapy. __IMAGE_2

"All the cells in our bodies contain transporters that are poised in cellular membranes and act as ‘gatekeepers?to allow the entry of certain substances, like nutrients, into the cell and promote the export of other substances, like toxins, out of the cell," says Professor Igor Stagljar, Department of Medical Genetics and Department of Biochemistry at the University of Toronto and lead author of the study. "When the function of these transporters is impaired, disease can result. This device gives us insights as to what proteins are interfering with this process."

iMYTH works by scanning cells to reveal proteins that fit with the transporters, the only screening system sophisticated enough to work with delicate membrane proteins. Simply, if two proteins interact in iMYTH, they will stain the yeast cell bl
'"/>

Source:University of Toronto


Page: 1 2

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
3. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
4. Technology for monitoring fetal oxygen during labor offers no apparent benefit
5. Technology exists to keep E. coli out of food
6. A bacterial genome reveals new targets to combat infectious disease
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Examination of internal wiring of yeast, worm, and fly reveals conserved circuits
9. NYU study reveals how brains immune system fights viral encephalitis
10. Study reveals new technique for fingerprinting environmental samples
11. Study reveals dramatic difference between breast cancers in US and Africa
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Technology reveals lock and key proteins behind diseases

(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
(Date:1/22/2015)... Washington , January 20, 2015 Investorideas.com, ... tech stocks, releases video from the CES 2015 (Consumer Electronics ... Apollo Robbins . Apollo shows how easily ... smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... have discovered a gene in plants that disrupts fertilization ... both the female and male reproductive cells. Their ... in the journal Current Biology, has been named the ... properties. Mutations that do not allow fertilization are ...
... of Grenoble, in France, have discovered that ... by doxorubicin and trastuzumab exposures. The research ... protects against acute chemotherapy toxicity in isolated ... January 2008 issue of Experimental Biology and ...
... - A group of signaling proteins known as Wnt ... muscle and other tissues - depend on a complex ... tissue-building cell sites, according to a study at Cincinnati ... the Retromer Complex - breaks down, the delivery of ...
Cached Biology News:Biologists find unusual plant gene: abstinence by mutual consent 2Biologists find unusual plant gene: abstinence by mutual consent 3A search for protection against chemotherapy cardiotoxicity 2Certain diseases, birth defects may be linked to failure of protein recycling system 2
(Date:1/22/2015)... CO / Rootstown, OH (PRWEB) January 22, 2015 ... detection platform, announced today that it has received AOAC-PTM Certifications ... O45, O1O3, O111, O121, and O145; collectively referred to as ... coli) O157, at 1 colony forming unit (cfu) per 325 ...
(Date:1/22/2015)... 2015 Selexis SA, a serial innovation ... Banks (RCBs) used for drug discovery to commercial manufacturing, ... include Next-Generation Sequencing (NGS) data packages. The ... manufacturing by ensuring the integrity of the gene, validation ...
(Date:1/22/2015)... CAMBRIDGE, Mass. , Jan. 22, 2015   GenoSpace , ... suite of tools to enable the broad use of genomic, ... today announced the appointment of Michelle Munson , CEO ... independent director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... BioTrends Research Group, Inc. finds that with the introduction ... the treatment of multiple sclerosis (MS), neurologists anticipate major shifts ... the launch of Gilenya, trial and uptake of Extavia, a ... tempered due to the perception that Extavia is a "me ...
... 2010 Prince of Wales Hospital in Hong Kong, China, ... treating cancer patients using the UNIQUE™ medical linear accelerator from ... for the first time last week, to deliver an image-guided ... in the lower part of the throat near the larynx. ...
... Scientists from Pacific Biosciences of California, Inc. (NASDAQ: ... molecule, real-time (SMRT) DNA sequencing technology to rapidly characterize ... in Haiti. Published Thursday in the New ... first whole genome sequence analysis and most detailed genetic ...
Cached Biology Technology:With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch 2With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch 3Prince of Wales Hospital in Hong Kong First in Asia to Offer Cancer Patients Image-Guided RapidArc® Radiotherapy Using the UNIQUE™ Radiotherapy System 2Prince of Wales Hospital in Hong Kong First in Asia to Offer Cancer Patients Image-Guided RapidArc® Radiotherapy Using the UNIQUE™ Radiotherapy System 3Prince of Wales Hospital in Hong Kong First in Asia to Offer Cancer Patients Image-Guided RapidArc® Radiotherapy Using the UNIQUE™ Radiotherapy System 4Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen 2Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen 3
... iLink makes it easy to supply microplates, ... Developed with operator convenience in mind, iLink ... ease of use. The iLink software is ... assays or sub-assays, that can be copied ...
... laboratory's requirements for data management and quality control. ... ... ... software for Staccato Systems and custom Allegro Modules allowing for the simple interface with more than ...
... demands continue to grow, the need for ... has become necessary, especially when discerning very ... innovative C1si Confocal Microscope System gives you ... capability not available in conventional confocal systems, ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
Biology Products: